Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaqian Han

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Frontiers in Cell and Developmental Biology|August 14, 2023
Organoids: opportunities and challenges of cancer therapyXianjie Jiang, Linda Oyang, Qiu Peng, et al.
Cell & Bioscience|July 24, 2020
The functions and mechanisms of prefoldin complex and prefoldin-subunitsJiaxin Liang, Longzheng Xia, Linda Oyang, et al.
Frontiers in Oncology|August 8, 2020
Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Frontiers in Oncology|May 16, 2020
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Oncogene|January 8, 2022
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activityJinguan Lin, Longzheng Xia, Linda Oyang, et al.
Cancer Communications (London, England)|January 13, 2024
Cellular metabolism: A key player in cancer ferroptosisXianjie Jiang, Qiu Peng, Mingjing Peng, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 2, 2025
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potentialYaqian Han, Shizhen Li, Linda Oyang, et al.
Cancer Communications (London, England)|September 21, 2024
Altered glycosylation in cancer: molecular functions and therapeutic potentialXuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
International Journal of Biological Sciences|May 19, 2025
Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significanceShiwen Cui, Qiu Peng, Qianfeng Ma, et al.
Molecular Cancer|February 6, 2021
The cancer metabolic reprogramming and immune responseLongzheng Xia, Linda Oyang, Jinguan Lin, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Cell and Developmental Biology|August 14, 2023
Organoids: opportunities and challenges of cancer therapyXianjie Jiang, Linda Oyang, Qiu Peng, et al.
Cell & Bioscience|July 24, 2020
The functions and mechanisms of prefoldin complex and prefoldin-subunitsJiaxin Liang, Longzheng Xia, Linda Oyang, et al.
Frontiers in Oncology|August 8, 2020
Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Frontiers in Oncology|May 16, 2020
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung CancerShiming Tan, Pin Yi, Heran Wang, et al.
Oncogene|January 8, 2022
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activityJinguan Lin, Longzheng Xia, Linda Oyang, et al.
Cancer Communications (London, England)|January 13, 2024
Cellular metabolism: A key player in cancer ferroptosisXianjie Jiang, Qiu Peng, Mingjing Peng, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 2, 2025
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potentialYaqian Han, Shizhen Li, Linda Oyang, et al.
Cancer Communications (London, England)|September 21, 2024
Altered glycosylation in cancer: molecular functions and therapeutic potentialXuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
International Journal of Biological Sciences|May 19, 2025
Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significanceShiwen Cui, Qiu Peng, Qianfeng Ma, et al.
Molecular Cancer|February 6, 2021
The cancer metabolic reprogramming and immune responseLongzheng Xia, Linda Oyang, Jinguan Lin, et al.
Pageof 8